转导(生物物理学)
生物
内耳
基因传递
遗传增强
基因
衣壳
计算生物学
耳蜗
免疫组织化学
基因表达
体内
细胞生物学
表情盒
病毒载体
听力损失
绿色荧光蛋白
转基因
报告基因
遗传学
载体(分子生物学)
信号转导
功能(生物学)
生物信息学
作者
Yong Tao,Cenfeng Chu,Zhenzhe Cheng,Shan Yin,Yilin Sun,Yuehua Chen,H Steve Zhang,Shuyue Bao,Boyu Yang,Baoyi Feng,Xianyu Huang,Yao Lu,Qiuxiang Yang,Xuegao Mao,Qifang Zhou,Chenxi Jin,Zhuo Duan,Guisheng Zhong,H Wu
标识
DOI:10.1016/j.ymthe.2026.07.021
摘要
Efficient and cell-specific gene delivery to cochlear inner hair cells (IHCs) remains a major challenge for inner ear gene therapy. Here, we identify and characterize a novel AAV2-derived capsid, AAV-WM04, that enables highly efficient and selective IHC transduction at low doses. Using an in vivo –directed evolution strategy, we generated a randomized AAV2 capsid library with 9–amino acid insertions and performed iterative selection in the adult mouse cochlea. Next-generation sequencing revealed enrichment of several variants, among which AAV-WM04 exhibited superior packaging efficiency and pronounced IHC tropism. AAV-WM04 achieved near-complete IHC transduction throughout the cochlear axis in adult mice, outperforming clinically relevant vectors with minimal off-target expression and no detectable ototoxicity. Selective IHC transduction was observed in non-human primates following local delivery, providing proof-of-concept evidence supporting the translational potential of AAV-WM04. Therapeutically, AAV-WM04 enabled efficient dual-AAV trans-splicing delivery of the large OTOF gene, resulting in uniform full-length otoferlin expression in IHCs. In a humanized Otof Q829X/Q829X mouse model, AAV-WM04 restored auditory function across a broad frequency range at relatively low doses and achieved sustained hearing recovery. These findings establish AAV-WM04 as a next-generation IHC-targeted vector with high efficiency, safety, and cross-species applicability for precision gene therapy of hereditary hearing loss.
科研通智能强力驱动
Strongly Powered by AbleSci AI